Cargando…

Editorial: Inflammation and immune diseases: Molecular targets for pathogenesis and treatment

Detalles Bibliográficos
Autor principal:	Wu, Fan-Rong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067895/ https://www.ncbi.nlm.nih.gov/pubmed/37021046 http://dx.doi.org/10.3389/fphar.2023.1174965

Ejemplares similares

Editorial: Targeting the Chemoattractant System in Inflammation
por: Hosoya, Tadashi, et al.
Publicado: (2021)

Editorial: New compounds, novel targets and mechanism study in inflammation-associated liver diseases
por: Wu, Baoming
Publicado: (2022)

Editorial: Ferroptosis as a novel therapeutic target for inflammation-related diseases
por: Liang, Yongyi, et al.
Publicado: (2023)

Editorial: Targeting inflammation to prevent complications in stroke
por: Varela, Lourdes M., et al.
Publicado: (2023)

Editorial: Pharmacological Approaches Targeting Neutrophilic Inflammation
por: Chernyak, Boris V., et al.
Publicado: (2021)

Editorial: Cancer of gastrointestinal tract: Novel insight into the molecular mechanisms related to inflammation and therapeutic targets
por: Banerjee, Aditi, et al.
Publicado: (2022)

Editorial: Innovative Biologics and Drugs to Target Renal Inflammation
por: Griffin, Matthew D., et al.
Publicado: (2020)

Editorial: Targeting Monocytes/Macrophages to Treat Atherosclerotic Inflammation
por: Corti, Alessandro, et al.
Publicado: (2020)

Editorial: New Therapeutic Approaches Against Inflammation and Immune Regulation in Metabolic Related Diseases
por: Lu, Yao, et al.
Publicado: (2022)

Editorial: Autophagy in Inflammation Related Diseases
por: Shao, Bo-Zong, et al.
Publicado: (2022)

Editorial: Pathogenesis of diabetic foot ulcers
por: Peng, Zhihong, et al.
Publicado: (2023)

Editorial: Cyclic Nucleotide Phosphodiesterases (PDEs) in Immune Regulation and Inflammation
por: Brocke, Stefan, et al.
Publicado: (2022)

Editorial: Nonalcoholic fatty liver disease: From pathogenesis to phytomedicine based on omics technology
por: Ji, Guang, et al.
Publicado: (2022)

Editorial: Inflammation and Fibrosis in the Gastrointestinal Tract and Liver: Mechanisms and Targets
por: Weiskirchen, Ralf, et al.
Publicado: (2021)

Editorial: Pharmacological approaches targeting neutrophilic inflammation: Volume II
por: Sokolov, Alexey V., et al.
Publicado: (2022)

Editorial: Novel Targets and the Application of Targeting Techniques in the Treatment of Cerebrovascular Disease
por: Liu, Zhidong, et al.
Publicado: (2019)

Editorial: Chronic Inflammation and Neurodegeneration in Retinal Disease
por: Petrillo, Francesco, et al.
Publicado: (2021)

SARS-CoV-2: Pathogenesis, Molecular Targets and Experimental Models
por: Kanimozhi, G., et al.
Publicado: (2021)

Editorial: Autophagy in inflammation related diseases, volume II
por: Shao, Bo-Zong, et al.
Publicado: (2023)

Editorial: Chronic inflammation and pharmacological interventions in cardiovascular diseases
por: Wang, Xiaoping, et al.
Publicado: (2022)

Editorial: Enteric inflammation and chronic diseases: Is there a link?
por: Marzocco, Stefania, et al.
Publicado: (2022)

Editorial: Platelets in Disease: From Biomarkers Discovery to Therapeutic Targets
por: Zhao, Fan, et al.
Publicado: (2022)

Heme Cytotoxicity and the Pathogenesis of Immune-Mediated Inflammatory Diseases
por: Larsen, Rasmus, et al.
Publicado: (2012)

The molecular pathogenesis of triptolide-induced hepatotoxicity
por: Hu, Yeqing, et al.
Publicado: (2022)

Editorial: Decreasing the Impact of Treatment Resistance in Schizophrenia: Identifying Novel Molecular Targets/Pathways to Increase Treatment Efficacy
por: Manchia, Mirko, et al.
Publicado: (2020)

Editorial: Antimycobacterial drug discovery: Molecular therapeutics and target identification
por: Gunosewoyo, Hendra, et al.
Publicado: (2022)

Editorial: The challenges of drug repurposing in diseases related to chronic inflammation
por: Collotta, Debora, et al.
Publicado: (2023)

Editorial: Gut Microbiota and Inflammation: Relevance in Cancer and Cardiovascular Disease
por: Parolini, Cinzia, et al.
Publicado: (2020)

Editorial: Inflammation in Cardiovascular Diseases: Role of the Endothelium and Emerging Therapeutics
por: Qin, Cheng Xue, et al.
Publicado: (2020)

Editorial: Chronic Inflammation and Neurodegeneration in Retinal Disease, Volume II
por: Bucolo, Claudio, et al.
Publicado: (2022)

Editorial: Targeting pumps, channels and transporters for the treatments of vascular, cardiovascular and kidney diseases
por: Zhang, Jinwei, et al.
Publicado: (2023)

Editorial: Insights in inflammation pharmacology: 2022
por: Patrignani, Paola, et al.
Publicado: (2023)

Editorial: Global excellence in inflammation pharmacology
por: Saha, Sukanya, et al.
Publicado: (2023)

Editorial: Eicosanoids and cytokines: Resolution of inflammation
por: Liu, Jun-Yan
Publicado: (2022)

Editorial: Insights in Inflammation Pharmacology: 2021
por: Patrignani, Paola, et al.
Publicado: (2022)

Editorial: Women in Inflammation Pharmacology: 2021
por: Patrignani, Paola
Publicado: (2022)

Editorial: Methods and applications in inflammation pharmacology
por: Schmidtchen, Artur, et al.
Publicado: (2022)

Editorial: Chronic inflammation and pharmacological interventions in cardiovascular diseases, volume II
por: Yan, Aiwei, et al.
Publicado: (2023)

Editorial: Novel Therapeutic Targets and Emerging Treatments for Fibrosis
por: Samuel, Chrishan S., et al.
Publicado: (2017)

Editorial: Mechanisms and New Targets for the Treatment of Chronic Pain
por: Nieto, Francisco Rafael, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_oj277hmuo0f9auvdkb89l7uqli